C4 Therapeutics, Inc. - COM STK (CCCC)

Q2 2022 Portfolio Holders as of 6/30/2022

Type / Class
Equity / COM STK
Number of holders
105
Total Shares
38.8M
Shares change
+2.3M
Total reported value, excl. options
$293M
Value change
-$38.9M
Put/Call ratio
0
Number of buys
62
Number of sells
-62
Price
$7.54
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.